FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2944329314> ?p ?o ?g. }

• W2944329314 endingPage "407" @default.
• W2944329314 startingPage "398" @default.
• W2944329314 abstract "Introduction Standard treatment of congenital haemophilia A is based on replacement therapy with coagulation factor VIII (FVIII) products. A major complication of FVIII therapy is the occurrence of IgG alloantibodies (inhibitors) that neutralize FVIII activity. Aim The aim of the analysis was estimating the risk of high‐titre inhibitor associated with the second‐generation full‐length product compared to third‐generation full‐length product and other recombinant FVIII (rFVIII). Methods We conducted a combined analysis of individual patient data from three large studies in previously untreated patients (PUPs) with severe haemophilia A. Results A total of 1109 PUPs were treated from 1993 to 2013 including 787 PUPs treated from 2004 onwards (primary analysis cohort). A total of 322 patients (29.0%) developed an inhibitor, of which 192 (17.3%) a high‐titre inhibitor. In the primary analysis set, 29.9% of patients developed an inhibitor and 17.2% a high‐titre inhibitor. The combined analysis indicated a lower risk of high‐titre inhibitor development for the third‐generation rFVIII product compared to the second‐generation rFVIII product (primary analysis: adjusted hazard ratio (HR) = 0.72, 95% CI: 0.49 to 1.06). Adjusted HR for all inhibitor development was significantly lower for the third‐generation product compared to the second‐generation product. Conclusion The trend of an increased risk of inhibitor development in PUPs for one recombinant product illustrates that extrapolation from one recombinant factor VIII product to other products might not be justified." @default.
• W2944329314 created "2019-05-16" @default.
• W2944329314 creator A5020151038 @default.
• W2944329314 creator A5020434406 @default.
• W2944329314 creator A5034006346 @default.
• W2944329314 creator A5035546452 @default.
• W2944329314 creator A5038124569 @default.
• W2944329314 creator A5055565211 @default.
• W2944329314 creator A5060884062 @default.
• W2944329314 creator A5065311756 @default.
• W2944329314 creator A5066122834 @default.
• W2944329314 creator A5071519850 @default.
• W2944329314 creator A5077911961 @default.
• W2944329314 creator A5080832874 @default.
• W2944329314 creator A5082451616 @default.
• W2944329314 creator A5082784881 @default.
• W2944329314 creator A5090350770 @default.
• W2944329314 date "2019-05-01" @default.
• W2944329314 modified "2023-10-10" @default.
• W2944329314 title "Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies" @default.
• W2944329314 cites W1525469616 @default.
• W2944329314 cites W1903245222 @default.
• W2944329314 cites W1963967196 @default.
• W2944329314 cites W1971837357 @default.
• W2944329314 cites W1997223335 @default.
• W2944329314 cites W1997760245 @default.
• W2944329314 cites W2017289138 @default.
• W2944329314 cites W2025981541 @default.
• W2944329314 cites W2042338172 @default.
• W2944329314 cites W2057950690 @default.
• W2944329314 cites W2075929635 @default.
• W2944329314 cites W2081441473 @default.
• W2944329314 cites W2098837289 @default.
• W2944329314 cites W2106536550 @default.
• W2944329314 cites W2108014527 @default.
• W2944329314 cites W2113676816 @default.
• W2944329314 cites W2143837758 @default.
• W2944329314 cites W2147887043 @default.
• W2944329314 cites W2154772948 @default.
• W2944329314 cites W2163909723 @default.
• W2944329314 cites W2164475789 @default.
• W2944329314 cites W2187945680 @default.
• W2944329314 cites W2328011698 @default.
• W2944329314 cites W2401865216 @default.
• W2944329314 cites W2469778904 @default.
• W2944329314 doi "https://doi.org/10.1111/hae.13747" @default.
• W2944329314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31066174" @default.
• W2944329314 hasPublicationYear "2019" @default.
• W2944329314 type Work @default.
• W2944329314 sameAs 2944329314 @default.
• W2944329314 citedByCount "17" @default.
• W2944329314 countsByYear W29443293142020 @default.
• W2944329314 countsByYear W29443293142021 @default.
• W2944329314 countsByYear W29443293142022 @default.
• W2944329314 countsByYear W29443293142023 @default.
• W2944329314 crossrefType "journal-article" @default.
• W2944329314 hasAuthorship W2944329314A5020151038 @default.
• W2944329314 hasAuthorship W2944329314A5020434406 @default.
• W2944329314 hasAuthorship W2944329314A5034006346 @default.
• W2944329314 hasAuthorship W2944329314A5035546452 @default.
• W2944329314 hasAuthorship W2944329314A5038124569 @default.
• W2944329314 hasAuthorship W2944329314A5055565211 @default.
• W2944329314 hasAuthorship W2944329314A5060884062 @default.
• W2944329314 hasAuthorship W2944329314A5065311756 @default.
• W2944329314 hasAuthorship W2944329314A5066122834 @default.
• W2944329314 hasAuthorship W2944329314A5071519850 @default.
• W2944329314 hasAuthorship W2944329314A5077911961 @default.
• W2944329314 hasAuthorship W2944329314A5080832874 @default.
• W2944329314 hasAuthorship W2944329314A5082451616 @default.
• W2944329314 hasAuthorship W2944329314A5082784881 @default.
• W2944329314 hasAuthorship W2944329314A5090350770 @default.
• W2944329314 hasConcept C104317684 @default.
• W2944329314 hasConcept C126322002 @default.
• W2944329314 hasConcept C141071460 @default.
• W2944329314 hasConcept C159654299 @default.
• W2944329314 hasConcept C203014093 @default.
• W2944329314 hasConcept C207103383 @default.
• W2944329314 hasConcept C2777232031 @default.
• W2944329314 hasConcept C2778385053 @default.
• W2944329314 hasConcept C3017906399 @default.
• W2944329314 hasConcept C3018907156 @default.
• W2944329314 hasConcept C32611913 @default.
• W2944329314 hasConcept C40767141 @default.
• W2944329314 hasConcept C41008148 @default.
• W2944329314 hasConcept C44249647 @default.
• W2944329314 hasConcept C55493867 @default.
• W2944329314 hasConcept C71924100 @default.
• W2944329314 hasConcept C76155785 @default.
• W2944329314 hasConcept C86803240 @default.
• W2944329314 hasConcept C90924648 @default.
• W2944329314 hasConcept C95190672 @default.
• W2944329314 hasConceptScore W2944329314C104317684 @default.
• W2944329314 hasConceptScore W2944329314C126322002 @default.
• W2944329314 hasConceptScore W2944329314C141071460 @default.
• W2944329314 hasConceptScore W2944329314C159654299 @default.
• W2944329314 hasConceptScore W2944329314C203014093 @default.
• W2944329314 hasConceptScore W2944329314C207103383 @default.
• W2944329314 hasConceptScore W2944329314C2777232031 @default.

• next